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ABSTRACT
Background: Malaria is a life-threatening infectious disease, which 
pose a public health challenge. Currently, reports of parasites resistance 
to artemisinin-based combination therapies is widespread. This has 
renewed calls for new antimalarial medications including herbal 
products for the treatment of malaria. This study was undertaken 
to scientifically assess the antiplasmodial potentials of Mist Amen 
Fevermix and Edhec Malacure, two polyherbal antimalarial products 
used for the management of uncomplicated malaria, and establish 
their phytochemical constituents.
Methods: Qualitative phytochemical screening based on standard 
analytical methods. The antiplasmodial activity was assessed in vitro 
by using Plasmodium falciparum. The SYBR® Green assay was used to 
measure parasite growth inhibition. In vivo activity was assessed with 
Plasmodium berghei parasites using the Rane’s curative method with 
artesunate as positive control.
Results: The phytochemical screening of the products revealed the 
presence of alkaloids, flavonoids, tannin, steroid and saponin. In the in 
vitro studies, the IC50 values for Edhec Malacure was 70.89 ng/mL and 
112.5ng/mL for Mist Amen Fevrmix. Artesunate exhibited an IC50 value 
of 1.571ng/mL. Edhec Malacure suppressed parasitemia by 76.17% (at 
4.25mg/kg-1) and Mist Amen Fevermix by 69.03% (at 1.56 mg/kg-1) in vivo. 
Conclusion: Mist Amen Fevrmix and Edhec Malacure Mixture 
demonstrated antiplasmodial activity and may be useful alternative 
antimalarial agents.
Keywords: antiplasmodial, alternative, antimalarial, phytochemical, uncomplicated malaria and parasites.
INTRODUCTION
Herbal products have been used for the treatment 
of diseases since time immemorial, and plant based 
remedies have formed the major part of traditional 
medical systems. They have been relied upon to 
prevent illness, support, promote and maintain 
human health and are used in every country of the 
world (Li et al., 2009; Shi et al., 2010). The world is 
home to diversified herbal products most of which 
have been widely used and marketed as antima-
larial products and for other diseases (Soelberg 
et al., 2015). Nevertheless, most of them have not 
been scientifically validated in terms of safety and 
efficacy. 
The increasing resistance to conventional anti-
malarial agents in clinical use has renewed the need 
for new therapies to mitigate the threat to life from 
malaria. Alternative efficacious drugs are urgently 
required to counter the threat posed by the malaria 
parasite. The emergence of drug resistance is a 
serious threat to global malaria control and erad-
ication efforts; thus warrants the introduction of 
potent new therapies against the malaria parasite 
(Muregi et  al., 2007). This situation urshered in 
the era of artemisinin-based combination therapy 
(ACT) as first-line treatment for uncomplicated 
falciparum malaria in all endemic areas (WHO, 
2015) to replace older antimalarial drugs due to 
resistance. However, recent evidence suggests that 
parasites are becoming resistant to the artemisinins 
in the Greater Mekong sub-region of Southeast 
Asia (Dondorp et al., 2009; Phyo et al., 2016; Pluijm 
et al., 2019). There is, therefore, the urgent need to 
carry out systematic investigations using modern 
scientific methods to establish the quality and 
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efficacy of available alternatives products, such as 
Mist Amen Fevrmix and Edhec Malacure, herbal 
prodcuts used in Ghana for the treatment of 
uncomplicated malaria.
Mist Amen Fevrmix is a finished herbal product 
prepared from the stem barks of Morinda lucida 
Benth (Family: Rubiaceae) and Parinari robusta 
Oliv. (Family: Chrysobalanaceae). The product, a 
decoction on the recommended Essential Herbal 
Medicines List (EHML) of the Ministry of Health 
and used in the Herbal Medicine Units in Ghana. 
It is approved by the Food and Drugs Authority 
(FDA) for public use Edhec Malacure is a finished 
herbal product prepared from the stem bark of 
Morinda lucida Benth (Family: Rubiaceae), leaves 
of Cleistopholis patens Benth. Engl. and Diels 
(Family: Annonaceae), and stem bark of Mangifera 
indica Linn. (Family: Anacardiaceae); it is not on 
the EHML, however, it is approved by the FDA also 
for public use.
The present study aimed at validating the qual-
ity and efficacy of Mist Amen Fevrmix and Edhec 
Malacure as alternatives for the management of 
uncomplicated malaria.
MATERIALS AND METHODS (Drugs, 
chemicals, solvents)
Five bottles each of Mist Amen Fevermix (330 mL) 
and Edhec Malacure (500 mL) were procured from 
the Pharmacy Department, Tafo Government 
Hospital, Kumasi, Ghana. SYBR Green, artesunate 
and Chloroquine powder, 5% O2, 5% CO2 and 90% 
Nitrogen were obtained from the Department of 
Pharmacology, KNUST, Kumasi. The following 
solvents Methanol, 1% lead acetate, ammoniacal 
alcohol, 1% H2SO4, 20% NaOH, dilute NH3, HCl, 
Fehling’s solution A and B, Dragendorff ’s reagent, 
chloroform and ethanol, were obtained from the 
Department of Pharmacognosy, KNUST, Kumasi. 
RBC (O-, Rhesus positive) Falcon and ACD tubes 
were obtained from the Tafo Government Hospital, 
Kumasi, Ghana.
Processing of Herbal Products and 
Preparation of Solutions
About 330mL of Mist Amen Fevermix and 500mL 
of Edhec Malacure were freeze-dried to powder 
form (3.1175 g and 2.6067 g) respectively. About 
25 mg of weighed powders (Mist Amen Fevermix 
and Edhec Malacure) were transferred into 15 mL 
Falcon tubes containing 5 mL of 70% ethanol to 
yield a stock concentration of 3000 μg/mL. An 
initial concentration of the study products was 
prepared by transferring 1.7 mL each into 15 mL 
Falcon tubes. The initially prepared concentration 
was serially diluted 8 fold to obtain 1000 μg/mL, 
500 μg/mL, 250 ug/mL, 125 μg/mL, 62.5 μg/mL, 
31.3 μg/mL, 15.6, 7.8 μg/mL and 3.9 μg/mL.
Ethical Approval
The study was carried out after ethical approval 
from the Ethics Committee on Animal Work, 
Department of Pharmacology, KNUST, Kumasi, 
Ghana. 
Parasite Sample Collection and Culturing.
In vitro susceptibility assays of Mist Amen Fevermix 
and Edhec Malacure Mixture were performed on 
P.  falciparum field isolate obtained from study 
participants at the Tafo Government Hospital. 
About 2.5 mL of blood samples containing 
P.   falciparum field isolatewere collected asepti-
cally from a venous puncture using the vacutainer 
system from six patients into ACD tubes and 
then stored in the liquid nitrogen. The parasites 
were then cultured based on a method previously 
described by (Hout et al., 2006) with some modifi-
cations. Parasite vials obtained from a liquid nitro-
gen tank were appropriately thawed in a water bath 
at a temperature of 37ºC. The vials (cell culture) 
were centrifuged at 2000 rpm for 10 minutes, and 
the resultant supernatant was discarded. An equal 
amount of a mixture of 3.5% NaCl in distilled water 
was added to each of the pellet, which was centri-
fuged at 2000 rpm for 10minutes. The pellets were 
gently disengaged and a 1 mL aliquot of complete 
parasite medium (5mL of L-glutamine, 2.5 mL of 
10 mg/mL and 50 mL Albumax in 500 mL of RPMI 
1640) was added and centrifuged again at 2000 rpm 
for 10 minutes (Jensen and Trager 1980). This 
procedure was duplicated, and the parasites were 
then suspended in 25mL BD Falcon tubes (culture 
flask) containing 200 µL freshly prepared pack of 
RBC (O-, Rhesus positive) and 5mL of complete 
parasite medium to have a haematocrit of 4%. A 2% 
Oxygen, 5.5% Carbon dioxide and 92.5% Nitrogen 
was used to gas the culture for 30 seconds for 25 mL 
culture flask. The flasks were quickly closed and put 
into an incubator (RS Biotech) at a temperature of 
37ºC in 5 percent O2, 5 percent CO2 and 90 percent 
Nitrogen. Parasites were allowed to grow for 3 days 
before the assay.
Parasite Preparation and In vitro 
Antiplasmodial Assay
After few days of adaption and growth of the para-
sites in the culture, they were harvested at the ring 
stage (trohpozoites) and initial parasitemia esti-
mated for each sample concentration using Giemsa 
stained slides and light microscope with 100X 
magnification. Samples were then processed and 
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2% hematocrit with 1% parasitemia was prepared 
using uninfected blood to make a total of 14 mL 
parasite mixture in a complete culture medium. 
One hundred microliters of each of the nine 
dilutions (1000 μg/mL, 500 μg/mL, 250  ug/mL, 
125 μg/mL, 62.5 μg/mL, 31.3 μg/mL, 15.6, 7.8 μg/mL 
and 3.9 μg/mL) were plated in duplicates 96 wells 
coastal plate. Test control drugs, 200 ng/mL 
Artesunate and 1000 ng/mL of Chloroquine were 
plated alongside with the Mist Amen Fevermix 
and Edhec Malacure. One hundred microliters of 
the parasite were mixed with 2 percent hemato-
crit and 1 percent parasitemia was added to each 
treated well starting from the 2nd well to the tenth 
well. One hundred microliters of parasite mixture 
were added to the 11th wells as a negative control 
and the procedure was repeated for the five other 
samples and the plates were arranged in a modular 
Chamber under an atmosphere of 5% Oxygen, 5% 
Carbon dioxide and 90% Nitrogen and then kept 
at 37°C for 72 h. The assay was paused by adding 
100 uL lysing buffer containing SYBR Green to each 
96-well micro-titre plates well and was thoroughly 
and gently spun to avoid the production of bubbles 
(Izumiyama et  al., 2009). The In vitro activities 
on strains of P.   falciparum were then determined 
(Izumiyama et al., 2009). A thin blood smear was 
prepared on microscope slides, fixed in absolute 
methanol, stained with 10% Giemsa in phosphate 
buffer under sterile conditions in a laminar flow 
safety cabinet (Hitachi Clean Bench, Japan) for 
10 minutes. The slides were dried and observed 
under a compound light microscope using 100X oil 
immersion objective lens and also using FLUOstar 
OPTIMA Fluorometer plate reader with control 
software version 2.20 at 470 nm and 520 nm wave-
lengths (Hout et al., 2006; Lambros and Vanderberg, 
1979). Various IC50 values were then determined.
The level of parasitaemia was estimated by 
measuring lactate dehydrogenase activity, based on 
a method as previously described (Kenmogne et al., 
2006). The results were expressed as the mean IC50 
(the concentration of a drug that reduced the level 
of parasitaemia to 50%).
In Vivo Assay
The experimental animals, Swiss albino mice of 
both sexes used for the study were obtained from the 
Noguchi Memorial Research Institute for Medical 
Research, Legon, Accra, Ghana. All the animals 
were allowed to acclimatize; housed for 7days and 
fed with mice feed and distilled water at ambient 
temperature. The parasite used for the inoculation, 
P.berghei, maintained in liquid nitrogen and stored 
at a temperature of -18°C, was obtained from the 
Department of Pharmacology, Kwame Nkrumah 
University of Science and Technology (KNUST).
Phytochemical analysis
Phytochemical analysis of the polyherbal prod-
ucts were performed for selected phytoconstit-
uents including: alkaloids, steroids, flavonoids, 
terpenoids, tannins and saponins using standard 
methods (Trease and Evans, 2009).
Experimental Design 
Parasite Inoculation
The test animals were quarantined for 7 days to 
acclimatize before infection. Standard inoculums 
of 1 × 107 P.  berghei infected erythrocytes in 0.2mL 
of blood were prepared by diluting infected blood 
with 0.9% (w/v) normal saline. Each mouse was 
inoculated by intraperitoneal injection with a blood 
suspension (0.2 mL) containing 1 × 107 parasitized 
erythrocytes (Moll et al., 2008).
Curative Test
The curative action of Mist Amen Fevermix and 
Edhec Malacure in Swiss albino mice were tested for 
using the methods described by Ryley and Peters 
(1970). Twenty mice were used for the evaluation 
of each product. Infected animals were divided into 
4  groups (positive, negative and two test groups 
(n = 5). Edhech Malacure was tested at one dose level 
of 4.25 mgkg-1 and Mist Amen Fevermix at a dose of 
1.56 mgkg-1/day). The doses were calculated based 
on the dose on the label of the products for humans. 
Two control groups (n = 5) were used, namely, 
positive control (infected and treated with 4 mgkg-1 
of artesunate) and negative control (infected and 
treated with distilled water). The treatments for 
the study samples lasted for 7consecutive days, the 
standard treatment lasted for three days. Blood 
samples were collected from the tip of the tails of 
the animals (Waako et al., 2005) on days 4, 7 and 
10 post- 4-day treatment.
Assessment and Monitoring of Parasitemia 
Parasitemia was assessed based on a method by 
(Tarkang et al.,(2015). Blood samples were collected 
from the tip of the tails of the animals on day 4. The 
blood samples were placed on a microscope slide, 
spread, dried, and fixed using methanol, and subse-
quently stained with 10% Giemsa stain for about 
30minutes. The stained film was washed off using 
phosphate buffer, pH 7.2 and allowed to dry. The 
film was immersed in oil and viewed at x100 magni-
fication. The parasitaemia level was determined by 
counting the number of parasitized erythrocytes 
out of 100 erythrocytes in random fields of the 
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microscope (Toma et al., 2015). Average percentage 
parasitemia was calculated using the formula: 
% Parasitaemia =
Total number of 
parasitized erythrocytes
× 100
Total number of 
erythrocytes counted
The average percentage of chemo suppression 
was calculated using the formula:
% Suppression =
 Parasitemia in Negative 
Control - Parasitemia in 
Test Group × 100
Parasitemia in Negative 
Control
Statistical Analysis
Each product (Mist Amen Fevermix and Edhec 
Malacure) was tested in duplicate and the product 
concentration that inhibits asexual Plasmodium 
falciparum parasite by 50% (IC50) were estimated 
from dose-response curves by non-linear regres-
sion analysis using Graph Pad Prism version 7.0 
Software (Graph Pad Software, San Diego, CA, 
USA)
RESULTS AND DISCUSSION
The results of the phytochemical screening of Mist 
Amen Fevermix and Edhec Malacure showed the 
presence of alkaloids, flavonoids, tannins, phytos-
terols and saponins.The results is as summarized in 
Table 1.
In Vitro and In Vivo Antiplasmodial Activity
The results for the in vitro antiplasmodial tests on 
Mist Amen Fevermix and Edhec Malacure against 
standard drugs are summarized in Table 2. Among 
the study products, the IC50 of Edhec Malacure was 
70.89 µg/mL as compared to 112.5 µg/mL exhibited 
by Mist Amen Fevermix Table 2. The standard drug 
artesunate exhibited an IC50 of 1.571 ug/mL.
In the in vivo study, there was an increase 
in weight in the positive control group of mice 
from16.98 ± 1.44 g to 18.98 ± 1.37 g (P = 0.0546) 
compared to Mist Amen Fevermix whose admin-
istration resulted in a decrease in weight from 
14.033 ± 4.69g to 13.767 ± 4.71g (P = 0.9308). The 
weight increase in Edhec Malacure was also not 
significant (p =0.95) Table 3.
For the in vivo antiplasmodial study, Edhec 
Malacure suppressed parasitemia by 76.17%, by 
Mist Amen Fevermix 69.03% with the positive 
control (artesunate) recording 98.06% suppression 
(Table 4).
Harnessing the potential clinical use of herbal 
products as alternative therapies to conventional 
drugs has many benefits to the population who rely 
on herbal products for their primary health care 
needs. This may enhance the safety and improve the 
quality of life of consumers. Mist Amen Fevermix 
and Edhec Malacure have been use in clinical prac-
tice in Ghana since the year 2011, for the treatment 
of uncomplicated malaria. The present study sought 
to validate their use by employing in vitro and in 
vivo antiplasmodial assays to evaluate the activity of 
Mist Amen Fevermix and Edhec Malacure. 
The in vitro anti-plasmodial assay of Mist Amen 
Fevermix and Edhec Malacure revealed that the 
highest antiplasmodial activity with an IC50 value of 
70.89 ng/mL with Mist Amen Fevrmix showing (IC 50 
value of 112.5 ng/mL). Artesunate, used as reference 
anti-malarial, exhibited a much higher activity with 
an IC50 value of 1.571 ng/mL than the test samples. 
This may be in agreement with previous reports on 
some herbal antimalaria products which recorded 
considerable activities with IC50 values in the range 
of 81.59 ± 1.48 ng/mL to 82.25 ± 1.91 ng/mL 
(Amoah et al., 2015). 
In vivo antiplasmodial activity of Mist Amen 
Fevermix and Edhec Malacure was investigated 
using the curative model on P.  berghei strain. Mist 
Amen Fevermix suppressed parasitaemia by 69.03% 
at a dose of 4.25 mgkg-1 bodyweight with Edhec 
Malacure suppressing parasitaemia by 76.17% at a 
dose of 1.56 mgkg1 body weight. The reference drug 
artesunate (at 4 mgkg-1 bodyweight) suppressed 
parasitaemia by 98.06%. The considerable 
anti-plasmodial activity of Mist Amen Fevermix and 
Edhec Malacure in established infection puts these 
products in the spotlight for malaria treatment in 
Table 1  Phytochemicals present in Mist Amen Fevermix and Edhec 
Malacure 
Phytoconstituents MAF MEM
Alkaloids + +
Tannins + +
Saponins + +
Flavonoids + +
Phytosterols + +
Terpenoids + +
Key: MAF- Mist Amen Fevermix, MEM- Edhec Malacure
Table 2  IC50 of Mist Amen Fevermix and Edhec Malacure in 
P.  falciparum-Infected Mice on Day 4 against Standard 
Drugs
Drugs IC50(ng/mL)
AS 1.571ng/mL 
MAF 112.5ng/mL
MEM 70.89ng/mL
Key: MAF- Mist Amen Fevermix, MEM- Edhec Malacure, AS-artesunate 
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developing countries. The reduction in parasitae-
mia is indicative of the curative potential of Mist 
Amen Fevermix and Edhec Malacure, antimalaria 
products that are already widely in use clinically.
The low sensitivity of the test products on  parasite 
growth in vitro (as shown by the IC50 values) was 
supplemented by the more potent antiplasmodial 
activity in vivo, which confirms the limited rele-
vance of in vitro testing (Rasoanaivo et al., 2004). 
The phytoconstituents observed in the test 
products were; alkaloids, saponins, tannins and 
flavonoids. The antiplasmodial effects of Mist Amen 
Fevrmix and Edhec Malacure could be due to the 
presence of these phytochemicals. It has been estab-
lished that, several classes of phytoconstituents 
present in herbal products are responsible for their 
antimalarial activity. Alkaloids are considered as 
an important phytoconstituent exhibiting diverse 
biological activities, particularly antimalarial activ-
ity (Kaur and S. Arora., (2015). Saponins are also 
known to posses antiprotozoal activity (Newbold 
et al., 1997).
The body weights of test animals were not 
significantly affected Table 3. 
CONCLUSION
Mist Amen Fevermix and Edhec Malacure possess 
antiplasmodial properties in vitro and in vivo, thus 
validating their clinical use in the management of 
uncomplicated malaria and as alternative antima-
larial agents. Their activities could be due to their 
phytochemical constituents; alkaloids, tannins, 
saponins, flavonoids and Phytosterols. 
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